Merrill Goozner 
The $800 Million Pill [EPUB ebook] 
The Truth behind the Cost of New Drugs

Ajutor

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit.
Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible–these engrossing accounts illustrate how medical breakthroughs actually take place.
The $800 Million Pill suggests ways that the government’s role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.

€26.99
Metode de plata

Cuprins

Introduction
Part I. Biohype
1. The Longest Search
2. Rare Profits
3. The Source of the New Machine
Part II. Directed Research
4. A Public-Private Partnership
5. The Divorce
6. Breakthrough!
7. The Failed Crusade?
Part III. Big Pharma
8. Me Too!
9. The $800 Million Pill
10. The Future of Innovation
Notes
Bibliography
Acknowledgments
Index

Despre autor

Merrill Goozner is former Chief Economics Correspondent at the Chicago Tribune.  Winner of six Peter Lisagor Awards, Goozner is a contributing editor for The American Prospect. His work has also appeared in the New York Times, Washington Post, Boston Magazine, Columbia Journalism Review, Washington Monthly, Fortune Small Business, Slate.com, and Salon.com, among other publications.

Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Limba Engleză ● Format EPUB ● Pagini 297 ● ISBN 9780520939288 ● Mărime fișier 1.2 MB ● Editura University of California Press ● Publicat 2004 ● Ediție 1 ● Descărcabil 24 luni ● Valută EUR ● ID 6541888 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM

Mai multe cărți electronice de la același autor (i) / Editor

144.005 Ebooks din această categorie